Multiplex Assay Kit for Monocyte Chemotactic Protein 3 (MCP3) ,etc. by FLIA (Flow Luminescence Immunoassay)

CCL7; FIC; MARC; NC28; MCP3; SCYA7; Chemokine C-C-Motif Ligand 7; Small Inducible Cytokine A7; Monocyte Chemoattractant Protein 3

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Monocyte Chemotactic Protein 3 (MCP3) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Monocyte Chemotactic Protein 3 (MCP3) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Monocyte Chemotactic Protein 3 (MCP3) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Monocyte Chemotactic Protein 3 (MCP3) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 90-99 95
EDTA plasma(n=5) 87-95 90
heparin plasma(n=5) 97-105 102
sodium citrate plasma(n=5) 84-103 90

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Monocyte Chemotactic Protein 3 (MCP3) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Monocyte Chemotactic Protein 3 (MCP3) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Monocyte Chemotactic Protein 3 (MCP3) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 91-99% 93-102% 78-103% 78-95%
EDTA plasma(n=5) 78-101% 87-105% 89-96% 86-93%
heparin plasma(n=5) 99-105% 86-104% 93-101% 81-89%
sodium citrate plasma(n=5) 99-105% 82-97% 92-105% 85-101%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:MCP3) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Journal of Periodontal Research Effect of omega 3 fatty acids plus low-dose aspirin on both clinical and biochemical profiles of patients with chronic periodontitis and type 2 diabetes: a randomized double blind placebo-controlled study Pubmed:25604769
Journal of Histochmistry and Cytochmistry Epigallocatechin-3-Gallate Attenuates Unilateral Ureteral Obstruction-Induced Renal Interstitial Fibrosis in Mice PubMed: 25549657
Cell Physiol Biochem MicroRNA-155 Promotes Atherosclerosis Inflammation via Targeting SOCS1 PubMed: 26159489
Cell Transplantation Ex vivo Pretreatment of Islets with Mitomycin C: Reduction in Immunogenic Potential of Islets by Suppressing Secretion of Multiple Chemotactic Factors. pubmed:28901184
NPG Asia Materials Molybdenum disulfide/graphene oxide nanocomposites show favorable lung targeting and enhanced drug loading/tumor-killing efficacy with improved … Articles:am2017225
FASEB Journal Immunomodulation by adoptive regulatory T-cell transfer improves Coxsackievirus B3-induced myocarditis Pubmed:29863913
Catalog No. Related products for research use of Mus musculus (Mouse) Organism species Applications (RESEARCH USE ONLY!)
RPA089Mu02 Recombinant Monocyte Chemotactic Protein 3 (MCP3) Positive Control; Immunogen; SDS-PAGE; WB.
RPA089Mu04 Recombinant Monocyte Chemotactic Protein 3 (MCP3) Positive Control; Immunogen; SDS-PAGE; WB.
RPA089Mu03 Recombinant Monocyte Chemotactic Protein 3 (MCP3) Positive Control; Immunogen; SDS-PAGE; WB.
RPA089Mu01 Recombinant Monocyte Chemotactic Protein 3 (MCP3) Positive Control; Immunogen; SDS-PAGE; WB.
PAA089Mu01 Polyclonal Antibody to Monocyte Chemotactic Protein 3 (MCP3) WB; IHC; ICC; IP.
PAA089Mu02 Polyclonal Antibody to Monocyte Chemotactic Protein 3 (MCP3) WB; IHC; ICC; IP.
LAA089Mu71 Biotin-Linked Polyclonal Antibody to Monocyte Chemotactic Protein 3 (MCP3) WB; IHC; ICC.
SEA089Mu ELISA Kit for Monocyte Chemotactic Protein 3 (MCP3) Enzyme-linked immunosorbent assay for Antigen Detection.
MEA089Mu Mini Samples ELISA Kit for Monocyte Chemotactic Protein 3 (MCP3) Enzyme-linked immunosorbent assay for Antigen Detection.
LMA089Mu Multiplex Assay Kit for Monocyte Chemotactic Protein 3 (MCP3) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.
KSA089Mu01 ELISA Kit DIY Materials for Monocyte Chemotactic Protein 3 (MCP3) Main materials for "Do It (ELISA Kit) Yourself".